Newsroom

Posters

  • November 11, 2011 - S-Nitrosoglutathione Reductase Inhibitors for the Prevention and Treatment of Experimental Colitis
  • August 28, 2011 - Structure – Activity Relationships of Pyrrole Based S-Nitrosoglutathione Reductase Inhibitors – Carboxamide Modification
  • July 14, 2011 - Heterozygous Deletion of S-Nitrosoglutathione Reductase in Mice Does Not Increase Nitrosative Inactivation of O6-Alkylguanine-DNA Alkyltransferase or Diethylnitrosamine-induced Hepatocarcinogenesis
  • May 3, 2011 - Oral S-Nitrosoglutathione Reductase Inhibitors Attenuate Pulmonary Inflammation and Decrease Airspace Enlargement in Experimental Models of COPD
  • March 27, 2011 - Discovery of S-nitrosoglutathione reductase inhibitors as potential agents to treat asthma, COPD and IBD
More posters

Privacy

Privacy Policy

N30 Pharmaceuticals, Inc. (“N30 Pharma”) believes in protecting your privacy. We do not collect any information on you, your hardware, your software or your web browsing before, during or after you visit this website, including by the use of cookies, log files or clear GIFs. We do not collect any personally identifying information, and we do not use any data from this website to identify you or to communicate with you in any way.

This website may, for your convenience and information, contain links to other websites not controlled by N30 Pharma. These sites may send you cookies and collect data and personal information. N30 Pharma is not responsible for the content or the privacy policies of those other websites to which this website may link.

Please Contact Us if you have questions or concerns about this Privacy Statement.